Activin receptor type IIA/B blockade increases muscle mass and strength, but compromises glycemic control in mice
Michala Carlsson, Emma Frank, Joan Miquel Màrmol, Mona Sadek Ali, Steffen Henning Raun, Edmund Battey, Nicoline R. Andersen, Andrea Irazoki, Camilla Lund, Carlos Henríquez‐Olguín, Martina Kubec Højfeldt, Pauline Blomquist, Frederik Duch Bromer, Gabriele Mocciaro, Andreas Lodberg, , Lykke Sylow
This study shows that blocking ActRIIA/IIB increases muscle mass and strength in mice but causes glucose intolerance and reduced voluntary activity.
Molecular Metabolism · Sep 27, 2025Peer-reviewedMolecular Biology